Background: Financial payments from the drug industry to US physicians are common.
Payments may influence physicians' clinical decision making and drug prescribing. Purpose …

Objectives To examine the accessibility and quality of drug company payment data in
Europe. Design Comparative policy review of payment data in countries with different …

There are prevalent financial relationships between dermatologists and pharmaceutical
companies in Japan. However, little was known about the extent of whole picture of the …

Objectives Limited evidence is available regarding the financial relationships between
gastroenterologists and pharmaceutical companies in Japan. This study analysed the …

Background: Financial relationships between healthcare professionals and pharmaceutical
companies have historically caused conflicts of interest and unduly influenced patient care …

This cross‐sectional study evaluated the magnitude of personal payments made by
pharmaceutical companies to pediatric hematologist‐oncologists (PHOs) board‐certified by …

Objective To provide an overview of non-research pharmaceutical payments to healthcare
organizations and professionals in Japan and evaluate data disclosure methods. Methods …

Clinical Practice Guidelines (CPGs) play significant roles in most medical fields. However,
little is known about the extent of financial Conflicts of Interest (FCOIs) related to …

Background Self-regulation of payment disclosure by pharmaceutical industry trade groups
is a major global approach to increasing transparency of financial relationships between …

Background Antimicrobial resistance (AMR), recognised as a serious and growing threat to
global health, is promoted by multiple drivers, including antibiotic use in the livestock sector …